The interrelation of the angiotensin and endothelin systems on the modulation of NAD(P)H oxidase

Canadian Journal of Physiology and Pharmacology

Volumn 84, Issue 1, 2006, Pages 21-28

  Laplante, Marc André ^a   De Champlain, Jacques ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Angiotensin; Endothelin; NAD(P)H oxidase; Superoxide anion

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ALDOSTERONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; APOCYNIN; ATORVASTATIN; CALPHOSTIN C; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; FASUDIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; KALLIKREIN; KETANSERIN; KININ; LU 283072; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RHO KINASE; SEROTONIN 2A RECEPTOR; SOMATOMEDIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; NONHUMAN; OBESITY; PRIORITY JOURNAL;

ANGIOTENSIN II; ANIMALS; CARDIOVASCULAR DISEASES; ENDOTHELIN-1; HUMANS; NADPH OXIDASE;

EID: 33745757778     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y05-146     Document Type: Conference Paper

References (61)

1. Amiri, F., Virdis, A., Neves, M.F., Iglarz, M., Seidah, N.G., Touyz, R.M., Reudelhuber, T.L., and Schiffrin, E.L. 2004. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation, 110: 2233-2240. doi: 10.1161/01.CIR.0000144462.08345. B9. PMID: 15466627.
2. Balakrishnan, S.M., Wang, H.D., Gopalakrishnan, V., Wilson, T.W., and McNeill, J.R. 1996. Effect of an endothelin antagonist on hemodynamic responses to angiotensin II. Hypertension, 28: 806-809. PMID: 8901827.
3. Beaucage, P., Iglarz, M., Servant, M., Touyz, R.M., and Moreau, P. 2005. Position of Src tyrosine kinases in the interaction between angiotensin II and endothelin in in vivo vascular protein synthesis. J. Hypertens. 23: 329-335. doi: 10.1097/00004872-200502000-00015. PMID: 15662221.
4. Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A., and Freeman, B.A. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA, 87: 1620-1624. PMID: 2154753.
5. Cai, H., Griendling, K.K., and Harrison, D.G. 2003. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24: 471-478. doi: 10.1016/S0165-6147(03)00233-5. PMID: 12967772.
6. Callera, G.E., Touyz, R.M., Tostes, R.C., Yogi, A., He, Y., Malkinson, S., and Schiffrin, E.L. 2005. Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src. Hypertension, 45: 773-779. doi: 10.1161/01.HYP. 0000154365.30593.d3. PMID: 15699470.
7. Chang, T., Wang, R., and Wu, L. 2005. Methylglyoxal-induced nitric oxide and peroxynitrite production in vascular smooth muscle cells. Free Radic. Biol. Med. 38: 286-293. doi: 10.1016/j.freeradbiomed.2004.10.034. PMID: 15607912.
8. Chao, J., and Chao, L. 2005. Kallikrein-kinin in stroke, cardiovascular and renal disease. Exp. Physiol. 90: 291-298. doi: 10.1113/expphysiol.2004. 028464. PMID: 15653716.
9. Cruzado, M.C., Risler, N.R., Miatello, R.M., Yao, G., Schiffrin, E.L., and Touyz, R.M. 2005. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation. Am. J. Hypertens. 18: 81-87. doi: 10.1016/j.amjhyper.2004.09.001. PMID: 15691621.
10. Dong, F., Zhang, X., Wold, L.E., Ren, Q., Zhang, Z., and Ren, J. 2005. Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1. Br. J. Pharmacol. 145: 323-333. doi: 10.1038/sj.bjp.0706193. PMID: 15765100.
11. Duerrschmidt, N., Wippich, N., Goettsch, W., Broemme, H.J., and Morawietz, H. 2000. Endothelin-1 induces NAD(P)H oxidase in human endothelial cells. Biochem. Biophys. Res. Commun. 269: 713-717. doi: 10.1006/bbrc.2000.2354. PMID: 10720482.
12. Fei, J., Viedt, C., Soto, U., Elsing, C., Jahn, L., and Kreuzer, J. 2000. Endothelin-1 and smooth muscle cells: induction of jun amino-terminal kinase through an oxygen radical-sensitive mechanism. Arterioscler. Thromb. Vasc. Biol. 20: 1244-1249. PMID: 10807739.
13. Fukui, T., Ishizaka, N., Rajagopalan, S., Laursen, J.B., Capers, Q., Taylor, W.R., et al. 1997. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ. Res. 80: 45-51. PMID: 8978321.
14. Gottlieb, R.A., Huang, C., Paromov, V., Tsukada, Y., and Wentworth, P. 2004. Role of cytochrome P450 in myocardial reperfusion injury. Cardiovasc. J. S. Afr. 15: S1.
15. Greene, E.L., Houghton, O., Collinsworth, G., Garnovskaya, M.N., Nagai, T., Sajjad, T., et al. 2000. 5-HT(2A) receptors stimulate mitogen-activated protein kinase via H(2)O(2) generation in rat renal mesangial cells. Am. J. Physiol. Renal Physiol. 278: F650-F658. PMID: 10751227.
16. Griendling, K.K. 2004. Novel NAD(P)H oxidases in the cardiovascular system. Heart, 90: 491-493. doi: 10.1136/hrt.2003.029397. PMID: 15084538.
17. Griendling, K.K., Minieri, C.A., Ollerenshaw, J.D., and Alexander, R.W. 1994. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74: 1141-1148. PMID: 8187280.
18. Gryglewski, R.J., Palmer, R.M., and Moncada, S. 1986. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature, 320: 454-456. doi: 10.1038/320454a0. PMID: 3007998.
19. Hahn, A.W., Resink, T.J., Scott-Burden, T., Powell, J., Dohi, Y., and Buhler, F.R. 1990. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul. 1: 649-659. PMID: 2078571.
20. Heitzer, T., Wenzel, U., Hink, U., Krollner, D., Skatchkov, M., Stahl, R.A., et al. 1999. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int. 55: 252-260. doi: 10.1046/j.1523-1755.1999.00229.x. PMID: 9893134.
21. Higashi, M., Shimokawa, H., Hattori, T., Hiroki, J., Mukai, Y., Morikawa, K., et al. 2003. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ. Res. 93: 767-775. doi: 10.1161/01.RES.0000096650. 91688.28. PMID: 14500337.
22. Hohler, B., Holzapfel, B., and Kummer, W. 2000. NADPH oxidase subunits and superoxide production in porcine pulmonary artery endothelial cells. Histochem. Cell Biol. 114: 29-37. PMID: 10959820.
23. Hong, H.J., Chan, P., Liu, J.C., Juan, S.H., Huang, M.T., Lin, J.G., and Cheng, T.H. 2004. Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells. Cardiovasc. Res. 61: 159-168. doi: 10.1016/j.cardiores.2003.10.019. PMID: 14732213.
24. Hwang, J., Saha, A., Boo, Y.C., Sorescu, G.P., McNally, J.S., Holland, S.M., et al. 2003. Oscillatory shear stress stimulates endothelial production of O2- from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J. Biol. Chem. 278: 47291-47298. doi: 10.1074/jbc.M305150200. PMID: 12958309.
25. Inoguchi, T., and Nawata, H. 2005. NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndrome. Curr. Drug Targets, 6: 495-501. doi: 10.2174/1389450054021927. PMID: 16026268.
26. Inoguchi, T., Li, P., Umeda, F., Yu, H.Y., Kakimoto, M., Imamura, M., et al. 2000. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes, 49: 1939-1945. PMID: 11078463.
27. Laplante, M.A., Wu, R., El Midaoui, A., and de Champlain, J. 2003. NAD(P)H oxidase activation by angiotensin II is dependent on p42/44 ERK-MAPK pathway activation in rat's vascular smooth muscle cells. J. Hypertens. 21: 927-936. doi: 10.1097/00004872-200305000-00017. PMID: 12714867.
28. Laplante, M.A., Wu, R., Moreau, P., and de Champlain, J. 2005. Endothelin mediates superoxide production in angiotensin II-induced hypertension in rats. Free Radic. Biol. Med. 38: 589-596. doi: 10.1016/j.freeradbiomed.2004.11.026. PMID: 15683715.
29. Lassegue, B., Sorescu, D., Szocs, K., Yin, Q., Akers, M., Zhang, Y., et al. 2001. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 88: 888-894. PMID: 11348997.
30. Lee, S.L., Wang, W.W., and Fanburg, B.L. 1998. Superoxide as an intermediate signal for serotonin-induced mitogenesis. Free Radic. Biol. Med. 24: 855-858. doi: 10.1016/S0891-5849(97)00359-6. PMID: 9586816.
31. Li, L., Fink, G.D., Watts, S.W., Northcott, C.A., Galligan, J.J., Pagano, P.J., and Chen, A.F. 2003. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation, 107: 1053-1058. doi: 10.1161/01.CIR.0000051459.74466.46. PMID: 12600921.
32. Lo, I.C., Shih, J.M., and Jiang, M.J. 2005. Reactive oxygen species and ERK 1/2 mediate monocyte chemotactic protein-1-stimulated smooth muscle cell migration. J. Biomed. Sci. 12: 377-388. doi: 10.1007/s11373-005-1703-2. PMID: 15917991.
33. Mata-Greenwood, E., Grobe, A., Kumar, S., Noskina, Y., and Black, S.M. 2005. Cyclic stretch increase VEGF expression in pulmonary arterial smooth muscle cells via TGF-{beta} 1 and reactive oxygen species: a requirement for NAD(P)H oxidase. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L288-L289. PMID: 15821013.
34. Miyauchi, T., and Masaki, T. 1999. Pathophysiology of endothelin in the cardiovascular system. Annu. Rev. Physiol. 61: 391-415. doi: 10.1146/annurev.physiol.61.1.391. PMID: 10099694.
35. Mollnau, H., Wendt, M., Szocs, K., Lassegue, B., Schulz, E., Oelze, M., et al. 2002. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 90: E58-E65. doi: 10.1161/01.RES.0000012569.55432.02. PMID: 11884382.
36. Morawietz, H., Weber, M., Rueckschloss, U., Lauer, N., Hacker, A., and Kojda, G. 2001. Upregulation of vascular NAD(P)H oxidase subunit gp91phox and impairment of the nitric oxide signal transduction pathway in hypertension. Biochem. Biophys. Res. Commun. 285: 1130-1135. doi: 10.1006/bbrc.2001.5312. PMID: 11478771.
37. Munzel, T., Hink, U., Heitzer, T., and Meinertz, T. 1999. Role for NADPH/NADH oxidase in the modulation of vascular tone. Ann. N. Y. Acad. Sci. 874: 386-400. PMID: 10415549.
38. Ohara, Y., Peterson, T.E., and Harrison, D.G. 1993. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91: 2546-2551. PMID: 8390482.
39. Park, J.Y., Park, K.G., Kim, H.J., Kang, H.G., Ahn, J.D., Kim, H.S., et al. 2005. The effects of the overexpression of recombinant uncoupling protein 2 on proliferation, migration and plasminogen activator inhibitor 1 expression in human vascular smooth muscle cells. Diabetologia, 48: 1022-1028. doi: 10.1007/s00125-005-1712-8. PMID: 15827742.
40. Patriarca, P., Cramer, R., Marussi, M., Rossi, F., and Romeo, D. 1971. Mode of activation of granule-bound NADPH oxidase in leucocytes during phagocytosis. Biochim. Biophys. Acta, 237: 335-338. PMID: 4398347.
41. Radi, R., Beckman, J.S., Bush, K.M., and Freeman, B.A. 1991a. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266: 4244-4250. PMID: 1847917.
42. Radi, R., Beckman, J.S., Bush, K.M., and Freeman, B.A. 1991b. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288: 481-487. doi: 10.1016/0003-9861(91)90224-7. PMID: 1654835.
43. Rao, G.N., and Berk, B.C. 1992. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 70: 593-599. PMID: 1371430.
44. Schleicher, E., Weigert, C., Rohrbach, H., Nerlich, A., Bachmeier, B., and Friess, U. 2005. Role of glucoxidation and lipid oxidation in the development of atherosclerosis. Ann. N. Y. Acad. Sci. 1043: 343-354. doi: 10.1196/annals.1333.041. PMID: 16037256.
45. Seshiah, P.N., Weber, D.S., Rocic, P., Valppu, L., Taniyama, Y., and Griendling, K.K. 2002. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ. Res. 91: 406-413. doi: 10.1161/01.RES.0000033523. 08033.16. PMID: 12215489.
46. Suh, Y.A., Arnold, R.S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., et al. 1999. Cell transformation by the superoxide-generating oxidase Mox1. Nature, 401: 79-82. PMID: 10485709.
47. Tojo, A., Onozato, M.L., Kobayashi, N., Goto, A., Matsuoka, H., and Fujita, T. 2005. Antioxidative effect of p38 mitogen-activated protein kinase inhibitor in the kidney of hypertensive rat. J. Hypertens. 23: 165-174. doi: 10.1097/00004872-200501000-00027. PMID: 15643139.
48. Touyz, R.M., Chen, X., Tabet, F., Yao, G., He, G., Quinn, M.T., Pagano, P.J., and Schiffrin, E.L. 2002. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ. Res. 90: 1205-1213. doi: 10.1161/01.RES.0000020404.01971.2F. PMID: 12065324.
49. Touyz, R.M., Yao, G., and Schiffrin, E.L. 2003. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 23: 981-987. PMID: 12663375.
50. Touyz, R.M., Yao, G., Viel, E., Amiri, F., and Schiffrin, E.L. 2004. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J. Hypertens. 22: 1141-1149. PMID: 15167449.
51. Ungvari, Z., Csiszar, A., Kaminski, P.M., Wolin, M.S., and Koller, A. 2004. Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system. Am. J. Pathol. 165: 219-226. PMID: 15215177.
52. Ushio-Fukai, M., Zafari, A.M., Fukui, T., Ishizaka, N., and Griendling, K.K. 1996. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J. Biol. Chem. 271: 23317-23321. PMID: 8798532.
53. Vaziri, N.D., and Ni, Z. 2005. Expression of NOX-I, gp91phox, p47phox and P67phox in the aorta segments above and below coarctation. Biochim. Biophys. Acta, 1723: 321-327. PMID: 15814300.
54. Virdis, A., Neves, M.F., Amiri, F., Touyz, R.M., and Schiffrin, E.L. 2004. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J. Hypertens. 22: 535-542. PMID: 15076159.
55. Warnholtz, A., Nickenig, G., Schulz, E., Macharzina, R., Brasen, J.H., Skatchkov, M., et al. 1999. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation, 99: 2027-2033. PMID: 10209008.
56. Wassmann, S., Laufs, U., Muller, K., Konkol, C., Ahlbory, K., Baumer, A.T., et al. 2002a. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 22: 300-305. PMID: 11834532.
57. Wassmann, S., Laufs, U., Stamenkovic, D., Linz, W., Stasch, J.P., Ahlbory, K., et al. 2002b. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation, 105: 2083-2091. doi: 10.1161/01.CIR.0000014618.91633.67. PMID: 11980689.
58. Wedgwood, S., Dettman, R.W., and Black, S.M. 2001. ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am. J. Physiol. Lung Cell. Mol. Physiol. 281: L1058-L1067. PMID: 11597896.
59. Wu, L., and de Champlain, J. 1999. Superoxide anion-induced formation of inositol phosphates involves tyrosine kinase activation in smooth muscle cells from rat mesenteric artery. Biochem. Biophys. Res. Commun. 259: 239-243. doi: 10.1006/bbrc.1999.0762. PMID: 10362493.
60. Wu, R., Laplante, M.A., and de Champlain, J. 2005. Cyclooxygenase-2 inhibitors attenuate angiotensin II-induced oxidative stress, hypertension, and cardiac hypertrophy in rats. Hypertension, 45: 1139-1144. doi: 10.1161/01.HYP.0000164572.92049.29. PMID: 15851630.
61. Yoshimoto, T., Fukai, N., Sato, R., Sugiyama, T., Ozawa, N., Shichiri, M., and Hirata, Y. 2004. Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells. Endocrinology, 145: 3331-3337. doi: 10.1210/en.2003-1583. PMID: 15070851.